A phase 2 basket trial of an ERK1/2 inhibitor (LY3214996) in combination with abemaciclib for patients whose tumors harbor pathogenic alterations in BRAF, RAF1, MAP2K1/2 ERK1/2, and NF1.

被引：0
|
作者：
Taza, Fadi
Durm, Greg Andrew
Opyrchal, Mateusz
Jalal, Shadia Ibrahim
Radovich, Milan
Schneider, Bryan P.
Turk, Anita Ahmed
机构：
[1] Indiana Univ, Simon Canc Ctr, Div Hematol & Oncol, Indianapolis, IN USA
[2] IU, Dept Hematol Oncol, Simon Comprehens Canc, Indianapolis, IN USA
[3] Indiana Univ, Simon Canc Ctr, Indianapolis, IN USA
[4] Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[5] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15088
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Inhibition of the ERK1/2 pathway by RanBPM
    Atabakhsh, Elnaz
    Schild-Poulter, Caroline
    CANCER RESEARCH, 2012, 72
  • [22] ERK and cell death: ERK1/2 in neuronal death
    Subramaniam, Srinivasa
    Unsicker, Klaus
    FEBS JOURNAL, 2010, 277 (01) : 22 - 29
  • [23] ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1
    Balmanno, Kathryn
    Kidger, Andrew M.
    Byrne, Dominic P.
    Sale, Matthew J.
    Nassman, Nejma
    Eyers, Patrick A.
    Cook, Simon J.
    BIOCHEMICAL JOURNAL, 2023, 480 (09) : 587 - 605
  • [24] The dimer interface of ERK1/2 provides an alternative targeting strategy to interfere with ERK1/2 mediated cardiac hypertrophy
    Tomasovic, A.
    Huemmert, M.
    Kramer, S.
    Gruse, T.
    Katus, H. A.
    Lohse, M. J.
    Mueller, O.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S4 - S5
  • [25] Erk1/2 signaling is required for Smad2 and Tgf-β2 induced Erk1/2 expression in cranial bones but not in cranial sutures
    Opperman, LA
    Fernandez, CR
    FASEB JOURNAL, 2005, 19 (05): : A1364 - A1364
  • [26] Combination of a novel ERK1/2 inhibitor (LY3214996) with CDK4 and CDK6 inhibitor (abemaciclib) enhances antitumor efficacy in KRAS mutant non-small cell lung cancer (NSCLC)
    Wu, Wenjuan
    Bhagwat, Shripad V.
    King, Constance
    Pratt, Susan
    Gong, Xueqian
    Stewart, Julie
    Jones, Bonita
    Flack, Robert
    Beckman, Richard
    Falcon, Beverly
    Manro, Jason
    McMillen, William T.
    Tiu, Ramon V.
    Peng, Sheng-Bin
    Reinhard, Christoph
    Joseph, Sajan
    Buchanan, Sean
    CANCER RESEARCH, 2017, 77
  • [27] Fragment-based discovery of a highly potent, orally bioavailable ERK1/2 inhibitor that modulates the phosphorylation and catalytic activity of ERK1/2
    Heightman, Tom D.
    Berdini, Valerio
    Braithwaite, Hannah
    Buck, Ildiko
    Cassidy, Megan
    Castro, Juan
    Courtin, Aurelie
    Day, James
    East, Charlotte
    Fazal, Lynsey
    Graham, Brent
    Griffiths-Jones, Charlotte
    Lyons, John
    Martins, Vanessa
    Muench, Sandra
    Munck, Joanne
    Norton, David
    O'Reilly, Marc
    Palmer, Nick
    Pathuri, Puja
    Reader, Mike
    Rees, David
    Rich, Sharna
    Richardson, Caroline
    Saini, Harpreet
    Thompson, Neil
    Wallis, Nicola
    Walton, Hugh
    Wilsher, Nicola
    Woolford, Alison
    Murray, Chris
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [28] CHARACTERIZATION OF HUMAN ERK1 AND ERK2 CDNAS - STRUCTURE-FUNCTION ANALYSIS OF HUMAN ERK1
    OWAKI, H
    MAKAR, R
    ROBBINS, D
    BOULTON, TG
    COBB, M
    GEPPERT, T
    FASEB JOURNAL, 1992, 6 (05): : A1983 - A1983
  • [29] Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence
    Zhang, Kai
    Chen, Hao
    Zhang, Bin
    Sun, Jiajia
    Lu, Jian
    Chen, Kangwu
    Yang, Huilin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (01): : 608 - 614
  • [30] ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1
    Busca, Roser
    Christen, Richard
    Lovern, Matthew
    Clifford, Alexander M.
    Yue, Jia-Xing
    Goss, Greg G.
    Pouyssegur, Jacques
    Lenormand, Philippe
    BMC EVOLUTIONARY BIOLOGY, 2015, 15
12345